Lipid bilayer simulations of CXCR4 with inverse agonists and weak partial agonists

被引:99
作者
Trent, JO
Wang, ZX
Murray, JL
Shao, WH
Tamamura, H
Fujii, N
Peiper, SC
机构
[1] Univ Louisville, Brown Canc Ctr 323, Louisville, KY 40202 USA
[2] Univ Louisville, JG Brown Modeling Facil, Louisville, KY 40202 USA
[3] Univ Louisville, Dept Med, Louisville, KY 40202 USA
[4] Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA
[5] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA
[6] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto, Japan
关键词
D O I
10.1074/jbc.M307850200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CXCR4 is a G protein- coupled receptor ( GPCR) that has multiple critical functions in normal and pathologic physiology that include regulation of the metastatic behavior of mammary carcinoma, and utilization as a co-receptor for infection by T- tropic strains of human immunodeficiency virus- 1. Molecular dynamic simulations of the rhodopsin- based homology model of CXCR4 were performed in a solvated lipid bilayer to reproduce the microenvironment of this integral membrane protein. The amino acids in CXCR4 necessary for interaction with an inverse agonist, T140, and a weak partial agonist, AMD3100, identified by alanine scanning mutants, were spatially consistent when computationally docked. Whereas T140 binds residues in extracellular domains and regions of the hydrophobic core proximal to the cell surface, amino acids in the central hydrophobic core are critical to binding of AMD3100. The physical localization of T140 binding to CXCR4 by biochemical analyses corroborated the molecular and computational approaches. The structural basis for the interaction of T140 and AMD3100 with CXCR4 confirms that the mechanisms used by these agents are different. This complementary utilization of molecular, physical, and computation analysis provides a powerful approach to elucidate GPCR conformation.
引用
收藏
页码:47136 / 47144
页数:9
相关论文
共 25 条
[1]   Structure and function in rhodopsin: Mapping light-dependent changes in distance between residue 316 in helix 8 and residues in the sequence 60-75, covering the cytoplasmic end of helices TM1 and TM2 and their connection loop CL1 [J].
Altenbach, C ;
Klein-Seetharaman, J ;
Cai, KW ;
Khorana, HG ;
Hubbell, WL .
BIOCHEMISTRY, 2001, 40 (51) :15493-15500
[2]   Protein-based virtual screening of chemical databases. II. Are homology models of G-protein coupled receptors suitable targets? [J].
Bissantz, C ;
Bernard, P ;
Hibert, M ;
Rognan, D .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2003, 50 (01) :5-25
[3]   Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities [J].
Brelot, A ;
Heveker, N ;
Montes, M ;
Alizon, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (31) :23736-23744
[4]   A 2ND GENERATION FORCE-FIELD FOR THE SIMULATION OF PROTEINS, NUCLEIC-ACIDS, AND ORGANIC-MOLECULES [J].
CORNELL, WD ;
CIEPLAK, P ;
BAYLY, CI ;
GOULD, IR ;
MERZ, KM ;
FERGUSON, DM ;
SPELLMEYER, DC ;
FOX, T ;
CALDWELL, JW ;
KOLLMAN, PA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (19) :5179-5197
[5]   Safe use of the CXCR4 inhibitor ALX40-4C in humans [J].
Doranz, BJ ;
Filion, LG ;
Diaz-Mitoma, F ;
Sitar, DS ;
Sahai, J ;
Baribaud, FD ;
Orsini, MJ ;
Benovic, JL ;
Cameron, W ;
Doms, RW .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (06) :475-486
[6]   Identification of CXCR4 domains that support coreceptor and chemokine receptor functions [J].
Doranz, BJ ;
Orsini, MJ ;
Turner, JD ;
Hoffman, TL ;
Berson, JF ;
Hoxie, JA ;
Peiper, SC ;
Brass, LF ;
Doms, RW .
JOURNAL OF VIROLOGY, 1999, 73 (04) :2752-2761
[7]   HIV-1 Entry Cofactor: Functional cDNA Cloing of a Seven-Transmembrane, G protein-Coupled Receptor [J].
Feng, Yu ;
Broder, Christopher C. ;
Kennedy, Paul E. ;
Berger, Edward A. .
JOURNAL OF IMMUNOLOGY, 2011, 186 (11) :872-877
[8]   Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor [J].
Gerlach, LO ;
Skerlj, RT ;
Bridger, GJ ;
Schwartz, TW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (17) :14153-14160
[9]   Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers [J].
Hendrix, CW ;
Flexner, C ;
MacFarland, RT ;
Giandomenico, C ;
Fuchs, EJ ;
Redpath, E ;
Bridger, G ;
Henson, GW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) :1667-1673
[10]   Molecular dynamics simulations on SDF-1α:: Binding with CXCR4 receptor [J].
Huang, XQ ;
Shen, JH ;
Cui, M ;
Shen, LL ;
Luo, XM ;
Ling, K ;
Pei, G ;
Jiang, HL ;
Chen, KX .
BIOPHYSICAL JOURNAL, 2003, 84 (01) :171-184